相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Enhanced chondrogenic phenotype of primary bovine articular chondrocytes in Fibrin-Hyaluronan hydrogel by multi-axial mechanical loading and FGF18
Bernardo P. Antunes et al.
ACTA BIOMATERIALIA (2020)
Identification of a FGF18-expressing alveolar myofibroblast that is developmentally cleared during alveologenesis
Andrew S. Hagan et al.
DEVELOPMENT (2020)
Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)?
Michael Ritchie et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection
Baek Gyu Jun et al.
PLOS ONE (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Benefit from pemigatinib in cholangiocarcinoma
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study
Hyo Jeong Kang et al.
LIVER CANCER (2019)
FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p
Jinglin Zhang et al.
ONCOGENE (2019)
Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma
Zhong-Zhe Lin et al.
LIVER INTERNATIONAL (2019)
Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma
Soon Sun Kim et al.
ANTICANCER RESEARCH (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Rotational Freedom, Steric Hindrance, and Protein Dynamics Explain BLU554 Selectivity for the Hinge Cysteine of FGFR4
Xiaojing Lin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer
Hagen Kulbe et al.
CELLS (2019)
Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
Jinglin Zhang et al.
CELLS (2019)
FGF19-FGFR4 Signaling in Hepatocellular Carcinoma
Aroosha Raja et al.
CELLS (2019)
The role of the fibroblast growth factor family in bone-related diseases
Jicheng Wang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer
Andreas Weiss et al.
MOLECULAR CANCER THERAPEUTICS (2019)
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma
Richard D. Kim et al.
CANCER DISCOVERY (2019)
Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma
Megan A. Hatlen et al.
CANCER DISCOVERY (2019)
Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
Gerd Jomrich et al.
CELLS (2019)
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
Takahiro Maeda et al.
BMC CANCER (2019)
Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone
Renata C. Pereira et al.
BONE (2019)
FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
Xihui Ying et al.
ONCOTARGETS AND THERAPY (2019)
Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects
Xiaoyun Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition
Vivek Subbiah et al.
CANCER DISCOVERY (2019)
Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field
Iliana Doycheva et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma
Pengyi Guo et al.
ONCOGENE (2018)
Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver
Guozhen Cui et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway
Juhua Zhuang et al.
ONCOLOGY RESEARCH (2018)
Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet
Garima Singhal et al.
MOLECULAR METABOLISM (2018)
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
Archita Agrawal et al.
MOLECULAR METABOLISM (2018)
Structural Alterations in Human Fibroblast Growth Factor Receptors in Carcinogenesis
D. S. Mikhaylenko et al.
BIOCHEMISTRY-MOSCOW (2018)
Lenvatinib as a therapy for unresectable hepatocellular carcinoma
Andrea Spallanzani et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara et al.
JAMA ONCOLOGY (2018)
A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma
Baojia Zou et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Stephane Champiat et al.
CLINICAL CANCER RESEARCH (2017)
Tivantinib for the treatment of hepatocellular carcinoma
Jan Best et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
Lixia Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Inhibition of the growth of hepatocellular carcinoma cells through fibroblast growth factor 18 suppressed by miR-139
Li Yang et al.
ONCOLOGY REPORTS (2017)
Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
Mei Zhou et al.
NATURE COMMUNICATIONS (2017)
Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma
Changhoon Yoo et al.
ONCOTARGET (2017)
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
Liang Wu et al.
SCIENTIFIC REPORTS (2017)
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
Bhavna N. Desai et al.
MOLECULAR METABOLISM (2017)
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma
Jaya Julie Joshi et al.
CANCER RESEARCH (2017)
Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage
Yongde Luo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate
Shumei Kato et al.
CLINICAL CANCER RESEARCH (2017)
Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis
Gloria Alvarez-Sola et al.
DIGESTIVE DISEASES (2017)
Expression of functional recombinant human fibroblast growth factor 8b and its protective effects on MPP+-lesioned PC12 cells
Nazi Chen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
FGF18 as a potential biomarker in serous and mucinous ovarian tumors
Saba El-Gendi et al.
TUMOR BIOLOGY (2016)
FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β-catenin signaling cascade via FGFR4 activation
Huakan Zhao et al.
ONCOTARGET (2016)
Biliary Cancer: Utility of Next-Generation Sequencing for Clinical Management
Milind Javle et al.
CANCER (2016)
Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma
Ke Li et al.
CANCER RESEARCH (2016)
A combined series of Fgf9 and Fgf18 mutant alleles identifies unique and redundant roles in skeletal development
Irene H. Hung et al.
DEVELOPMENTAL BIOLOGY (2016)
Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium
Clare A. Flannery et al.
ENDOCRINOLOGY (2016)
Mechanistic Target of Rapamycin Complex 1 Is an Essential Mediator of Metabolic and Mitogenic Effects of Fibroblast Growth Factor 19 in Hepatoma Cells
Zhi Yi Wan et al.
HEPATOLOGY (2016)
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Masaru Katoh
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation
Xinyu Liu et al.
MEDICAL ONCOLOGY (2016)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference
Gunter Schumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
Yan Li et al.
ONCOTARGET (2016)
Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
Dewei Ye et al.
SCIENTIFIC REPORTS (2016)
Fibroblast Growth Factor 8 Expression in GT1-7 GnRH-Secreting Neurons Is Androgen-Independent, but Can Be Upregulated by the Inhibition of DNA Methyltransferases
Megan L. Linscott et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease
Nobuyuki Itoh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions
Kyung-Ju Choi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Targeting FGFR Signaling in Cancer
Mehdi Touat et al.
CLINICAL CANCER RESEARCH (2015)
Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers
Willscott E. Naugler et al.
GASTROENTEROLOGY (2015)
Fibroblast Growth Factor Receptor 3 Isoforms: Novel Therapeutic Targets for Hepatocellular Carcinoma?
Jakob Paur et al.
HEPATOLOGY (2015)
MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma
Feng Fang et al.
JOURNAL OF HEPATOLOGY (2015)
Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
Nature Reviews Clinical Oncology (2015)
Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma
Haiyang Xie et al.
TUMOR BIOLOGY (2015)
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
Margit Hagel et al.
CANCER DISCOVERY (2015)
Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development
Qingyang Gu et al.
ONCOTARGET (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target
Wen-Yue Liu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development
Iker Uriarte et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Autocrine Fibroblast Growth Factor 18 Signaling Mediates Wnt-Dependent Stimulation of CD44-Positive Human Colorectal Adenoma Cells
Inga Koneczny et al.
MOLECULAR CARCINOGENESIS (2015)
Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma
Ming-Jen Sheu et al.
PLOS ONE (2015)
FGF8 promotes colorectal cancer growth and metastasis by activating YAP1
Rui Liu et al.
ONCOTARGET (2015)
Fibroblast Growth Factor-5 Participates in the Progression of Hepatic Fibrosis
Hiromi Hanaka et al.
EXPERIMENTAL ANIMALS (2014)
Fibroblast Growth Factor Signaling in Liver Carcinogenesis
Dalbir S. Sandhu et al.
HEPATOLOGY (2014)
Fibroblast Growth Factor 21 Protects Against Acetaminophen-Induced Hepatotoxicity by Potentiating Peroxisome Proliferator-Activated Receptor Coactivator Protein-1α-Mediated Antioxidant Capacity in Mice
Dewei Ye et al.
HEPATOLOGY (2014)
A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma
Lei Zhong et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A short story of Klotho and FGF23: a deuce of dark side or the savior?
F. Fevzi Ersoy
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations
Howard R. Mellor
LIVER INTERNATIONAL (2014)
FGF Receptors: Cancer Biology and Therapeutics
Masaru Katoh et al.
MEDICINAL RESEARCH REVIEWS (2014)
Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis
Jian Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
Chaofeng Yang et al.
BMC GASTROENTEROLOGY (2013)
MicroRNA-140-5p Suppresses Tumor Growth and Metastasis by Targeting Transforming Growth Factor β Receptor 1 and Fibroblast Growth Factor 9 in Hepatocellular Carcinoma
Hao Yang et al.
HEPATOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Clinical Trials in Hepatocellular Carcinoma: An Update
Ying-Chun Shen et al.
Liver Cancer (2013)
The fibroblast growth factor receptor 2-mediated extracellular signal-regulated kinase 1/2 signaling pathway plays is important in regulating excision repair cross-complementary gene 1 expression in hepatocellular carcinoma
Gang Chen et al.
BIOMEDICAL REPORTS (2013)
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
Seiki Miura et al.
BMC CANCER (2012)
βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
Xunshan Ding et al.
CELL METABOLISM (2012)
Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma
Yuan Yang et al.
MOLECULAR CARCINOGENESIS (2012)
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
Chaofeng Yang et al.
PLOS ONE (2012)
Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
Dorothy M. French et al.
PLOS ONE (2012)
Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System
Maria U. Latasa et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Emerging Signaling Pathways in Hepatocellular Carcinoma
Agrin Moeini et al.
LIVER CANCER (2012)
Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Eric T. Sawey et al.
CANCER CELL (2011)
Connective Tissue Growth Factor Autocriny in Human Hepatocellular Carcinoma: Oncogenic Role and Regulation by Epidermal Growth Factor Receptor/Yes-Associated Protein-Mediated Activation
Raquel Urtasun et al.
HEPATOLOGY (2011)
Up-Regulation of the Fibroblast Growth Factor 8 Subfamily in Human Hepatocellular Carcinoma for Cell Survival and Neoangiogenesis
Christine Gauglhofer et al.
HEPATOLOGY (2011)
Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
Nobuyuki Itoh et al.
JOURNAL OF BIOCHEMISTRY (2011)
Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma
Ann-Lii Cheng et al.
ONCOLOGY (2011)
Reduced Expression of Fibroblast Growth Factor Receptor 2IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth
Thomas Amann et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Extending the Family Table: Insights From Beyond Vertebrates Into the Regulation of Embryonic Development by FGFs
Sarah Tulin et al.
BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS (2010)
Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease
Nobuyuki Itoh
CELL AND TISSUE RESEARCH (2010)
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Klementina Fon Tacer et al.
MOLECULAR ENDOCRINOLOGY (2010)
The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma
Norifumi Harimoto et al.
ONCOLOGY (2010)
Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
Ye-Rang Yun et al.
Journal of Tissue Engineering (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform ΔEx2p73 in Human Hepatocellular Tumors
Josefa Castillo et al.
GASTROENTEROLOGY (2009)
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
Han Kiat Ho et al.
JOURNAL OF HEPATOLOGY (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis
S. Sagmeister et al.
BRITISH JOURNAL OF CANCER (2008)
FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
Alexei Kharitonenkov et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models
Lr Desnoyers et al.
ONCOGENE (2008)
Functional evolutionary history of the mouse Fgf gene family
Nobuyuki Itoh et al.
DEVELOPMENTAL DYNAMICS (2008)
FGF18 in colorectal tumour cells: autocrine and paracrine effects
Gudrun Sonvilla et al.
CARCINOGENESIS (2008)
Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation
Valeria R. Mas et al.
TRANSPLANTATION (2007)
The Fgf families in humans, mice, and zebrafish: Their evolutional processes and roles in development, metabolism, and disease
Nobuyuki Itoh
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Liver-specific activities of FGF19 require Klotho beta
Benjamin C. Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Direct interactions of Runx2 and canonical Wnt signaling induce FGF18
Martina I. Reinhold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate
Zhonghao Liu et al.
DEVELOPMENTAL BIOLOGY (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis
Xinqiang Huang et al.
MOLECULAR CARCINOGENESIS (2006)
Identification of a hormonal basis for gallbladder filling
Mihwa Choi et al.
NATURE MEDICINE (2006)
Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells
Josefa Castillo et al.
CANCER RESEARCH (2006)
Receptor specificity of the fibroblast growth factor family - The complete mammalian FGF family
Xiuqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Evolution of the Fgf and Fgfr gene families
N Itoh et al.
TRENDS IN GENETICS (2004)
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling
Y Midorikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma
H Yoshiji et al.
HEPATOLOGY (2002)
Expression patterns of fibroblast growth factors-18 and-20 in mouse embryos is suggestive of novel roles in calvarial and limb development
MK Hajihosseini et al.
MECHANISMS OF DEVELOPMENT (2002)
分享论文
